Article | REF: BIO7150 V1

Biochips - Present and future Applications

Author: Véronique ANTON LEBERRE

Publication date: May 10, 2013

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Français

6. Biochips market

Biochips were developed and marketed in the 1990s. Since then, the market has undergone tremendous growth. Valued at $760 million in 2010, it is expected to reach $1,425.2 million by 2015. The Morgan Stanley report of May 2010 shows that the microarray market is essentially held by three companies. Affymetrix, the main industry leader in microarrays and associated reagents, accounts for 38% of market share, Illumina for 34% and Agilent for 17% (figure 16 and table 3 ). Competition is fierce, and Roche/NimbleGen, which holds just 5.5% of the market, has decided to cease its microarray business by the end of 2012, in order to focus on sequence capture and next-generation sequencing. The "gene expression" application...

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Analysis and Characterization

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Biochips market